2.09 (-%)
As of Nov 01, 2024
Source:
Bioatla, Inc is a clinical-stage biopharmaceutical company developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | ( 858 ) 558-0708 |
| Industry | manufacturing |
| CEO | Jay M. Short |
| Website | www.bioatla.com |